Syringomatous Tumour Presenting as Inversion of a Supernumerary Nipple by Louise Öwall, Henrik Mygind, Åsa Rosenborg, Anne-Vibeke Lænkholm

Get full text

Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data. by Anne Bruun Krøigård, Mads Thomassen, Anne-Vibeke Lænkholm, Torben A Kruse, Martin Jakob Larsen

Get full text

Survival outcomes for HER2-low breast cancer: Danish national data by Michael Sode, Kåre Nielsen, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen, Anne-Vibeke Lænkholm

Get full text

High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients by Kåre Nielsen, Michael Sode, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen, Anne-Vibeke Lænkholm

Get full text

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. by Maria B Lyng, Anne-Vibeke Lænkholm, Rolf Søkilde, Karina H Gravgaard, Thomas Litman, Henrik J Ditzel

Get full text

SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatment. by Sarah L Larsen, Anne-Vibeke Laenkholm, Anne Katrine Duun-Henriksen, Martin Bak, Anne E Lykkesfeldt, Tove Kirkegaard

Get full text

Intratumor Genetic Heterogeneity of Breast Carcinomas as Determined by Fine Needle Aspiration and TaqMan Low Density Array by Maria B. Lyng, Anne-Vibeke Lænkholm, Niels Pallisgaard, Werner Vach, Ann Knoop, Martin Bak, Henrik J. Ditzel

Get full text

Immune cell populations in the tumour environment following calcium electropora­tion for cutaneous metastasis: a histopathological study by Mille Vissing, Sandra Sinius Pouplier, Lars Munch Larsen, Stine Krog Frandsen, Alexey Lodin, Anne-Vibeke Lænkholm, Julie Gehl

Get full text

Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study. by Maria B Lyng, Anne-Vibeke Lænkholm, Qihua Tan, Werner Vach, Karina H Gravgaard, Ann Knoop, Henrik J Ditzel

Get full text

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management by Giuseppe Curigliano, Fatima Cardoso, Michael Gnant, Nadia Harbeck, Judy King, Anne-Vibeke Laenkholm, Frédérique Penault-Llorca, Aleix Prat

Get full text

Locoregional Lymph Node Metastasis from Clinically Occult Breast Cancer: Prognostic Significance of Mastectomy by Andreas Werner Nærum, Emil Villiam Holm-Rasmussen, Ilse Vejborg, Ann Søegaard Knoop, Anne-Vibeke Lænkholm, Niels Kroman, Tove Filtenborg Tvedskov

Get full text

Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer by Annette R. Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M. B. Jylling, Jeanette D. Jensen, Anne‐Vibeke Lænkholm, Ann S. Knoop, Henrik J. Ditzel

Get full text

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression. by Anne Bruun Krøigård, Martin Jakob Larsen, Anne-Vibeke Lænkholm, Ann S Knoop, Jeanette Dupont Jensen, Martin Bak, Jan Mollenhauer, Mads Thomassen, Torben A Kruse

Get full text

Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000 by Aleksandar M. Kostov, Maj-Britt Jensen, Bent Ejlertsen, Mads Thomassen, Caroline Maria Rossing, Inge S. Pedersen, Annabeth H. Petersen, Lise Lotte Christensen, Karin A.W. Wadt, Anne-Vibeke Lænkholm

Get full text

Neo-train: study protocol and feasibility results for a two-arm randomized controlled trial investigating the effect of supervised exercise during neoadjuvant chemotherapy on tumou... by Eva Kjeldsted, Gunn Ammitzbøll, Lars Bo Jørgensen, Alexey Lodin, Rasmus Dahlin Bojesen, Silvia Gonzalez Ceballos, Susanne Rosthøj, Anne-Vibeke Lænkholm, Søren T. Skou, Sandy Jack, Julie Gehl, Susanne Oksbjerg Dalton

Get full text

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes by Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Anne-Vibeke Lænkholm, Åke Borg, Anders Kvist, Therese Törngren, Uffe Birk Jensen, Susanne Eriksen Boonen, Mads Thomassen, Thorkild Terkelsen

Get full text

Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes by Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Anne‑Vibeke Lænkholm, Åke Borg, Anders Kvist, Therese Törngren, Uffe Birk Jensen, Susanne Eriksen Boonen, Mads Thomassen, Thorkild Terkelsen

Get full text

Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness by Lars v. B. Andersen, Martin J. Larsen, Helen Davies, Andrea Degasperi, Henriette Roed Nielsen, Louise A. Jensen, Lone Kroeldrup, Anne-Marie Gerdes, Anne-Vibeke Lænkholm, Torben A. Kruse, Serena Nik-Zainal, Mads Thomassen

Get full text

A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics by Philippe Weitz, Masi Valkonen, Leslie Solorzano, Circe Carr, Kimmo Kartasalo, Constance Boissin, Sonja Koivukoski, Aino Kuusela, Dusan Rasic, Yanbo Feng, Sandra Sinius Pouplier, Abhinav Sharma, Kajsa Ledesma Eriksson, Leena Latonen, Anne-Vibeke Laenkholm, Johan Hartman, Pekka Ruusuvuori, Mattias Rantalainen

Get full text

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit by Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen, Henrik J. Ditzel

Get full text